Lipitor, Atorvastatin Newswire (Page 9)

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 309 in Lipitor, Atorvastatin (generic)

  1. New drugs help Pfizer to get wellRead the original story w/Photo

    Aug 3, 2016 | Nashua Telegraph

    Rising sales of Pfizer Inc.'s key new medicines and prospects that more drugs will be approved soon have analysts speculating the biggest U.S. drugmaker won't break up after all. For five years, the maker of Viagra and fibromyalgia and pain treatment Lyrica has been mulling a split up that might enable the resulting pieces to grow faster.

    Comment?

  2. Pfizer - reports - big drop - in profitRead the original story

    Aug 2, 2016 | The Gleaner

    Rising sales of Pfizer Inc's key new medicines and prospects that more drugs will be approved soon have analysts speculating that the biggest United States drugmaker will not break up after all. For five years, the maker of Viagra and fibromyalgia and pain treatment Lyrica has been mulling a split-up that might enable the resulting pieces to grow faster.

    Comment?

  3. Pfizer Investors Mood Dampened by Second Quarter EarningsRead the original story

    Aug 2, 2016 | GuruFocus.com

    Pharma major Pfizer raised its earnings guidance for 2016 after the first quarter results, increasing their 2016 revenue expectation to be in the range of $51 billion to $53 billion - a full two billion higher than their previous projection of $49 billion to $51 billion. After terminating its plan for a $150 billion mega-merger with Allergan earlier this year, Pfizer reported 11% revenue growth for the second quarter and 15% growth during the first half of this year compared to last year.

    Comment?

  4. Pfizer beats forecasts despite big drop in profitRead the original story w/Photo

    Aug 2, 2016 | Salt Lake Tribune

    Rising sales of Pfizer Inc.'s key new medicines and prospects more drugs will be approved over the next couple years have analysts speculating the biggest U.S. drugmaker won't break up after all. For the past five years, the maker of Viagra and fibromyalgia and pain treatment Lyrica has been mulling a split up that might enable the resulting pieces to grow faster.

    Comment?

  5. Mr Justice Arnold refers questions on Article 3(b) SPC Regulation to CJEURead the original story w/Photo

    Jul 29, 2016 | IPKat

    2. If the answer to question is no, is the absence of a granted marketing authorisation at the date of the application for a certificate an irregularity which can be cured under Article 10 of the SPC Regulation once the marketing authorisation has been granted? The SPC Regulation Nothing makes the AmeriKat happier than SPC law . For those who have better things to do with their time than to understand the wonderful world of SPCs or to follow the myriad of national and CJEU decisions in this area, the key points are as follows: By law, before a medicinal product can be placed on the market, it requires a MA.

    Comment?

  6. A new way to save on prescription drugsRead the original story w/Photo

    Jul 25, 2016 | The Wichita Eagle

    The apps have similar functions: they compare prescription drug costs, or specific co-pay costs, with geographical proximity to the user; offer coupons through the app; and provide drug-specific use and risk information. The apps compare prescription drug costs with geographical proximity to the user, offer coupons through the app, and provide drug-specific use and risk information.

    Comment?

  7. Eating unlimited amounts of healthy fats significantly slashes risk...Read the original story w/Photo

    Jul 20, 2016 | NewsTarget.com

    It may sound too good to be true, but a recent study has shown that a diet that includes an unlimited amount of healthy fats is actually helpful in preventing heart disease, diabetes and breast cancer. A meta-study led by US Department of Veterans Affairs research scientist Dr. Hanna Bloomfield revealed that the so-called "Mediterranean diet" - which can include large amounts of monounsaturated fat and omega-3 fatty acids - lowered the risk of heart attacks and strokes by 29 percent, type 2 diabetes by 30 percent and breast cancer by 57 percent.

    Comment?

  8. Replacing big pharma's products: How good are the generic options?Read the original story

    Jul 19, 2016 | Washington Times

    Big pharma and its big price tags have been the target for many a politician seeking to lower the cost of health care in the U.S. Martin Shkreli and his questionable big-pharma persona are an easy target and embodiment of how some continue to squeeze increasing profits out of America's declining health. Drug prices have been identified by both sides of the aisle as a possible solution to stave off people's possible bankruptcies due to health care costs.

    Comment?

  9. Good Question: How Do Prescription Drugs Get Their Names?Read the original story w/Photo

    Jul 18, 2016 | CBS Local

    TV is part of CBS Television Stations, a division of CBS Corp. and one of the largest network-owned station groups in the country. Click here for WCCO-TV news stories Send us your breaking news tips [...] 830 WCCO Welcome to News Radio 830 WCCO on CBSMinnesota.com! WCCO is part of CBS Radio, a division of CBS Corp. and one of the largest network-owned station groups in the country.

    Comment?

  10. The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit modelRead the original story w/Photo

    Jul 15, 2016 | BioMed Central

    Restenosis remains to be a major limitation of percutaneous transluminal angioplasty for diabetic patients with peripheral vascular disease . Despite of stations routine implements to prevent such progress, its exact effect is unclear.

    Comment?

  11. Could Statins Help Fight Cancer?Read the original story w/Photo

    Jul 11, 2016 | MedicineNet

    Some cancer patients who take cholesterol -lowering statins may live longer than those not on these heart medications, a study from Britain suggests. While it did not prove a cause-and-effect connection, the study of nearly 1 million cancer patients found that those taking statin drugs such as Lipitor and Crestor appeared to have: "We need to further investigate the reasons for patients with high cholesterol having improved mortality in four of the most common cancers," said senior researcher Dr. Rahul Potluri, a clinical lecturer at Aston University School of Medicine in Birmingham.

    Comment?

  12. Statins May Help Fight CancerRead the original story w/Photo

    Jul 11, 2016 | News Max

    Some cancer patients who take cholesterol-lowering statins may live longer than those not on these heart medications, a study from Britain suggests. While it did not prove a cause-and-effect connection, the study of nearly 1 million cancer patients found that those taking statin drugs such as Lipitor and Crestor appeared to have: a 22 percent lower risk of dying from lung cancer, a 43 percent lower risk of dying from breast cancer, a 47 percent lower risk of dying from prostate cancer, and a 30 percent lower risk of dying from colon cancer.

    Comment?

  13. Could Statins Help Fight Cancer? StudyRead the original story

    Jul 10, 2016 | BioSpace

    Some cancer patients who take cholesterol-lowering statins may live longer than those not on these heart medications, a study from Britain suggests.

    Comment?

  14. What Is a Blockbuster Drug?Read the original story w/Photo

    Jul 8, 2016 | Fox News

    Blockbuster drugs are those that generate at least $1 billion in revenue a year for the pharmaceutical companies that produce them.While it's true that many pharmaceutical companies are extremely profitable, there's also a lot of time, work, and money that goes into the development of new drugs. That's why certain breakthrough drugs are a real reason for pharma companies and their investors to celebrate -- especially those that wind up being blockbusters.

    Comment?

  15. Could Statins Help Fight Cancer?Read the original story w/Photo

    Jul 8, 2016 | HON

    Some cancer patients who take cholesterol-lowering statins may live longer than those not on these heart medications, a study from Britain suggests. While it did not prove a cause-and-effect connection, the study of nearly 1 million cancer patients found that those taking statin drugs such as Lipitor and Crestor appeared to have: "We need to further investigate the reasons for patients with high cholesterol having improved mortality in four of the most common cancers," said senior researcher Dr. Rahul Potluri, a clinical lecturer at Aston University School of Medicine in Birmingham.

    Comment?

  16. on Mental Illness: Medical ComplicationsRead the original story

    Jul 7, 2016 | Berkeley Daily Planet

    This week's column does not specifically cover all possible medication side effects of the drugs prescribed for psychiatric problems; there are too many to list here, and many are quite common. Instead, I am focusing on some of the things that shorten the lifespans of persons with mental illness.

    Comment?

  17. Study: Brand-Name Drugs' High Copays Soak Medicare Part D PatientsRead the original story w/Photo

    Jul 6, 2016 | KRMG-AM Tulsa

    A new study takes a fresh measure of generic drugs' price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013. Copayments averaged $42 for both Crestor, a cholesterol medication, and Nexium, taken for acid reflux, according to researchers whose study was published Wednesday in Health Affairs.

    Comment?

  18. John Hoffmire: Replacing big pharma's products: how good are the generic options?Read the original story w/Photo

    Jul 4, 2016 | Deseret News

    One of the easiest ways to reduce drug prices is by replacing more brand-name drugs with generic drugs, or generic substitution . Big pharma and its big price tags have been the target for many a politician seeking to lower the cost of health care in the U.S. Martin Shkreli and his questionable big-pharma persona are an easy target and embodiment of how some continue to squeeze increasing profits out of America's declining health.

    Comment?

  19. Best Stocks to Buy in a CrashRead the original story w/Photo

    Jun 27, 2016 | The Motley Fool

    Brexit is causing some investors to sell. But for those investors with a long-term horizon, it may prove more savvy to buy shares in leaders like Microsoft, ExxonMobil, and Pfizer instead.

    Comment?

  20. Effects of atorvastatin on atrial remodeling in a rabbit model of...Read the original story w/Photo

    Jun 23, 2016 | BioMed Central

    Accumulating evidence suggests that myeloperoxidase is involved in atrial remodeling of atrial fibrillation . Statins could reduce the MPO levels in patients with cardiovascular diseases.

    Comment?